<unk> , sold under the brand name Duavee in the US and Duavive in the EU, is a fixed-dose combination medication for the treatment of menopause symptoms and postmenopausal osteoporosis. It contains the selective<unk> receptor modulator<unk>  and<unk><unk> . It is taken by mouth. The combination was approved for medical use in the United States in October 2013, and in the European Union in December 2014.
Bazedoxifene/conjugated estrogens
Endoxifen
Tamoxifen
N,N-Didesmethyltamoxifen
Estradiol undecylate/norethisterone enanthate
N-Desmethyltamoxifen
High-dose estrogen
Estradiol/norethisterone acetate